HLA-A*02:01 & B2M Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Lerapolturev | Phase 2 Clinical | National Cancer Institute, Istari Oncology Inc, Duke University Medical Center | Ependymoma; Medulloblastoma; Solid tumours; Glioblastoma; Oligodendroglioma; Urinary Bladder Neoplasms; Brain Neoplasms; Breast Neoplasms; Gliosarcoma; Astrocytoma; Carcinoma, Embryonal; Glioma; Melanoma | Details | |
| NTX-1088 | Phase 1 Clinical | Nectin Therapeutics Ltd | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |